Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 290, pseudogene (RN7SL290P) is a human pseudogene sequence highly homologous to the functional 7SL RNA gene, which is the RNA component of the signal recognition particle (SRP). Pseudogenes such as RN7SL290P result from reverse transcription of a functional RNA (in this case 7SL RNA) and integration into the genome. Unlike the parental 7SL RNA, which is fundamental for protein targeting to the endoplasmic reticulum, RN7SL290P lacks both coding potential and known regulatory function—it is not expressed as a functional RNA and does not encode protein. There is currently no evidence for a biological or disease role, nor interaction with drugs. Pseudogenes are non-coding and generally non-functional genomic relics, and RN7SL290P is not a therapeutic target or receptor[1][3][4].
Not applicable (as no drugs interact with this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 290, pseudogene (RN7SL290P).